TMUS
T-Mobile US, Inc.
TMUS has the edge over UCL overall, supported by lower modeled downside and stronger valuation.
UCL
uCloudlink Group Inc.
UCL's outlook is improving, though it still trails on the overall score.
TMUS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
TMUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
UCL Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Weak | |
| Strong |
UCL's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
TMUS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $171 | — |
| Current | 16x | $171 | — |
| Cheap | 21x | $218 | +27% |
| Fair | 26x | $274 | +60% |
| Expensive | 56x | $581 | +240% |
Historical ranges are pointers, not guarantees.
TMUS's PE is in its cheap range at 16x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
UCL PE Valuation
UCL has no meaningful PE right now: it lost money over the past year.
TMUS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for TMUS, with profitability improving.
UCL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect UCL to return to profit, with revenue growing.
TMUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.49 | +30% |
| Q3 2026 | $10.37 | -0.2% |
| Q2 2026 | $9.56 | -9.7% |
| Q1 2026 | $9.41 | -8.1% |
| Q4 2025 | $9.72 | +0.6% |
| Q3 2025 | $10.39 | +18% |
| Q2 2025 | $10.59 | +33% |
| Q1 2025 | $10.24 | +39% |
| Q4 2024 | $9.66 | +39% |
TMUS has the stronger earnings trend. Trailing diluted EPS is down 0.2% for TMUS versus UCL down 20%.
UCL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2024 | $0.12 | +$0.27 |
| Q1 2024 | $0.03 | +$0.36 |
| Q4 2023 | $0.08 | +$0.74 |
| Q3 2023 | $0.10 | +$1.27 |
| Q2 2023 | -$0.15 | +$1.12 |
| Q1 2023 | -$0.33 | +$1.02 |
| Q4 2022 | -$0.66 | +$0.96 |
| Q3 2022 | -$1.17 | +$0.35 |
UCL has returned to profit: it earned $0.12 per share over the past year, after losing money the year before. Its recent earnings include one-off gains.
TMUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.6B | +7.4% |
| Q2 2026 | $22.8B | +7.9% |
| Q1 2026 | $23.1B | +11% |
| Q4 2025 | $24.3B | +11% |
| Q3 2025 | $22B | +8.9% |
| Q2 2025 | $21.1B | +6.9% |
| Q1 2025 | $20.9B | +6.6% |
| Q4 2024 | $21.9B | +6.8% |
TMUS has the edge over UCL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +3.4 points |
| Q2 2026 | 24% | -0.6 points |
| Q1 2026 | 19% | -3.5 points |
| Q4 2025 | 15% | -5.6 points |
| Q3 2025 | 21% | -3.2 points |
| Q2 2025 | 25% | +1.3 points |
| Q1 2025 | 23% | +2.6 points |
| Q4 2024 | 21% | +4 points |
TMUS has the edge over UCL on profitability, with a higher operating margin.
UCL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $18.2M | -5.9% |
| Q1 2026 | $16.9M | -10% |
| Q4 2025 | $22.3M | -14% |
| Q3 2025 | $21.2M | -16% |
| Q2 2025 | $19.4M | -13% |
| Q1 2025 | $18.7M | +3.4% |
| Q4 2024 | $26M | +19% |
| Q3 2024 | $25.2M | +5.6% |
UCL's revenue has slid since its 2019 peak: $18M last quarter, down 5.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -16% | -20 points |
| Q1 2026 | -16% | -13 points |
| Q4 2025 | 8.5% | +15 points |
| Q3 2025 | 0.6% | -13 points |
| Q2 2025 | 4.2% | -5.9 points |
| Q1 2025 | -2.5% | -5.3 points |
| Q4 2024 | -6.6% | +1.9 points |
| Q3 2024 | 13% | -0.7 points |
UCL's operating margin was −16% last quarter, down 20 points from the same quarter a year ago.
TMUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +5.3% |
| Q2 2026 | $4.8B | +4.4% |
| Q1 2026 | $4.6B | +4.6% |
| Q4 2025 | $4.2B | +25% |
| Q3 2025 | $4.8B | +15% |
| Q2 2025 | $4.6B | +32% |
| Q1 2025 | $4.4B | +79% |
| Q4 2024 | $3.3B | +2% |
TMUS has the edge over UCL on cash generation, producing positive trailing cash flow while its opponent burns cash.
UCL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.1M | -$2M |
| Q1 2026 | -$8.7M | -$8.7M |
| Q4 2025 | $4.4M | +$7.8M |
| Q3 2025 | -$1.4M | -170% |
| Q2 2025 | -$1.1M | -135% |
| Q1 2025 | -$64K | -105% |
| Q4 2024 | -$3.5M | -$80K |
| Q3 2024 | $2M | +1.2% |
UCL has burned cash in six of the last eight quarters: −$9M over the past year, against −$3M the year before.
TMUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -10.8M shares |
| 1 year | -4.9% | -55M shares |
| 3 years | -8.8% | -103M shares |
| 5 years | -15% | -182M shares |
| Available history | +24% | +207M shares |
TMUS has the edge over UCL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.4B |
| Q2 2026 | $2.3B |
| Q1 2026 | $4.8B |
| Q4 2025 | $2.4B |
| Q3 2025 | $2.5B |
| Q2 2025 | $2.6B |
| Q1 2025 | $2.5B |
| Q4 2024 | $4.7B |
TMUS spent $12B buying back its own shares over the past year, down 1.7% from the year before.
UCL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +163K shares |
| 1 year | +1.3% | +478K shares |
| 3 years | +33% | +9.3M shares |
| 5 years | +44% | +11.6M shares |
UCL has 38M diluted shares, up 1.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
TMUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.4x | Moderate |
TMUS's net debt is less than a year of its operating earnings (EBITDA).
UCL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -3.1x | Net Cash |
| Q1 2026 | -2.1x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -1.8x | Net Cash |
| Q2 2025 | -4.0x | Net Cash |
| Q2 2024 | -3.4x | Net Cash |
| Q1 2024 | -7.9x | Net Cash |
| Q4 2023 | -4.4x | Net Cash |
UCL has the edge over TMUS on leverage, with a lower net debt burden relative to earnings.
TMUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 42.1 | Neutral |
TMUS's weekly RSI is 48 (neutral) and its Stochastic is 42 (neutral).
UCL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 19.1 | Oversold |
| Stochastic | 4.7 | Oversold |
UCL's weekly RSI is 19 (oversold) and its Stochastic is 5 (oversold).
TMUS PE vs Communication Services Sector
| Metric | TMUS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 16x | Same PE |
| PE % | 1 | 26 | 25 pts below |
TMUS is trading at 16x earnings, in line with the Communication Services sector's median of 16x.
UCL PE vs Communication Services Sector
| Metric | UCL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 16x | — |
UCL has no meaningful PE right now: it lost money over the past year.
TMUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $159.1 | 7.5% above |
| 20 week MA | $172.0 | 0.5% below |
| 50 week MA | $187.8 | 8.9% below |
| 100 week MA | $212.9 | 20% below |
| 200 week MA | $188.7 | 9.4% below |
TMUS has the edge over UCL on trend strength, trading above more of its moving averages.
UCL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.25 | 12% below |
| 20 week MA | $0.50 | 56% below |
| 50 week MA | $1.07 | 79% below |
| 100 week MA | $1.49 | 85% below |
| 200 week MA | $1.90 | 88% below |
UCL is in a downtrend: it's below all five of its weekly moving averages, and 88% below its 200-week average.
TMUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $77.2 | $132.9 | +72% |
| 2021 | $132.9 | $119.9 | -9.8% |
| 2022 | $119.9 | $140.0 | +17% |
| 2023 | $140.0 | $160.3 | +15% |
| 2024 | $160.3 | $223.0 | +39% |
| 2025 | $223.0 | $201.0 | -9.9% |
| 2026 YTD | $201.0 | $171.0 | -15% |
TMUS has the edge over UCL on returns for 2026, with the stronger performance.
UCL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.5 | $10.4 | -37% |
| 2021 | $10.4 | $3.30 | -68% |
| 2022 | $3.30 | $3.97 | +20% |
| 2023 | $3.97 | $1.75 | -56% |
| 2024 | $1.75 | $2.40 | +37% |
| 2025 | $2.40 | $2.05 | -15% |
| 2026 YTD | $2.05 | $0.22 | -89% |
UCL has finished lower in four of the last six years. It's down 89% so far in 2026.